제이피아이헬스케어
Financials
Valuation Metrics
제이피아이헬스케어's Market Cap is ₩394B. Ranked #1842 of 2,410 in KR market (top 76%), #1138 of 1,631 on KOSDAQ (top 70%), #196 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 85%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 39.36B KRW | KR#1,842/2,410 Sec#196/231 |
| Revenue | 48.47B KRW | KR#1,808/2,410 Sec#125/231 |
| Net Income | 4.84B KRW | KR#1,229/2,410 Sec#84/231 |
| Total Assets | 82.38B KRW | KR#1,918/2,410 Sec#157/231 |
| Net Assets | 63.05B KRW | KR#1,756/2,410 Sec#147/231 |
| Value | ||
| P/E | 8.13x | KR#749/2,410 Sec#37/231 |
| P/B | 0.62x | KR#1,110/2,410 Sec#61/231 |
| P/S | 0.81x | KR#1,328/2,410 Sec#76/231 |
| EV/EBITDA | 8.85x | KR#597/2,410 Sec#27/231 |
| FCF Yield | 5.30% | KR#863/2,410 Sec#48/231 |
| Profitability | ||
| ROE | 7.68% | KR#822/2,410 Sec#56/231 |
| ROA | 5.88% | KR#637/2,410 Sec#51/231 |
| Op. Margin | 10.03% | KR#519/2,410 Sec#45/231 |
| Financial Health | ||
| Debt Ratio | 30.65% | KR#603/2,410 Sec#71/231 |
| Total Debt | 10.98B KRW | KR#1,586/2,410 Sec#142/231 |
| FCF | 2.09B KRW | KR#1,078/2,410 Sec#76/231 |
| Cash | 7.36B KRW | KR#1,850/2,410 Sec#164/231 |
| Current Ratio | 7.52x | KR#160/2,410 Sec#35/231 |
| Net Debt/EBITDA | 0.74x | KR#705/2,410 Sec#45/231 |
| Dividend | ||
| Div. Yield | 3.19% | KR#646/2,410 Sec#30/231 |
| Performance | ||
| 1Y Return | -60.11% | KR#2,160/2,410 Sec#202/231 |
| 1M Return | -13.08% | KR#1,264/2,410 Sec#131/231 |
| From 52W High | -62.66% | KR#1,719/2,410 Sec#142/231 |
| 1Y MDD | -65.40% | KR#1,736/2,410 Sec#148/231 |
| Trading | ||
| Volume | 1,766 shares | KR#2,283/2,410 Sec#227/231 |
| Trading Value | 13.6M KRW | KR#2,218/2,410 Sec#223/231 |
| Foreign Own. | 0.98% | KR#2,038/2,410 Sec#199/231 |
| Per Share | ||
| EPS | 948 KRW | KR#743/2,410 Sec#51/231 |
| BPS | 12,350 KRW | KR#835/2,410 Sec#57/231 |
Company Info
JPI Healthcare, a small and medium-sized venture company established in 1980 and renamed in 2010, specializes in the development and manufacturing of X-ray-based imaging diagnostic core components, including grids and various imaging devices. The company produces and sells next-generation medical imaging equipment such as digital X-ray medical imaging devices, digital tomosynthesis, and mobile low-dose, high-precision CT systems. Its products are supplied to over 300 global companies, including GE, Siemens, and Philips. JPI Healthcare is headquartered in Guro-gu, Seoul Metropolitan City.